Showing results (1771-1780 of 2,346) with videos related to
Sort By:
Pageof 235
The AAPS Journal|May 22, 2010
Mass spectrometry screening reveals peptides modulated differentially in the medial prefrontal cortex of rats with disparate initial sensitivity to cocaineElena V Romanova, Ji Eun Lee, Neil L Kelleher, et al.The AAPS Journal|June 29, 2010
Breast cancer resistance protein (BCRP) and sulfotransferases contribute significantly to the disposition of genistein in mouse intestineWei Zhu, Haiyan Xu, Stephen W J Wang, et al.The AAPS Journal|July 14, 2010
Bladder tissue pharmacokinetics of intravesical mitomycin C and suramin in dogsLeijun Hu, M Guillaume Wientjes, Jing Li, et al.The AAPS Journal|July 14, 2010
Ligand-binding mass spectrometry to study biotransformation of fusion protein drugs and guide immunoassay development: strategic approach and application to peptibodies targeting the thrombopoietin receptorMichael P Hall, Colin Gegg, Kenneth Walker, et al.The AAPS Journal|July 14, 2010
Controlled crystallization of the lipophilic drug fenofibrate during freeze-drying: elucidation of the mechanism by in-line Raman spectroscopyHans de Waard, Thomas De Beer, Wouter L J Hinrichs, et al.The AAPS Journal|July 24, 2010
Application of quantitative pharmacology in development of therapeutic monoclonal antibodiesMohammad Tabrizi, Cherryl Funelas, Hamza SuriaThe AAPS Journal|September 18, 2010
Fishing for the hidden peptidome in health and disease (drug abuse)Lloyd D Fricker, Jonathan V SweedlerThe AAPS Journal|September 22, 2010
Modeling disease progression in acute stroke using clinical assessment scalesKristin E Karlsson, Justin J Wilkins, Fredrik Jonsson, et al.The AAPS Journal|June 17, 2010
Peptidomics of the prolyl peptidasesAnna Mari Lone, Whitney M Nolte, Arthur D Tinoco, et al.The AAPS Journal|December 25, 2010
Dopamine D2 occupancy as a biomarker for antipsychotics: quantifying the relationship with efficacy and extrapyramidal symptomsRik de Greef, Alan Maloney, Per Olsson-Gisleskog, et al.Pageof 235